Older age is a strong predictor of accelerated human immunodeficiency virus (HIV) disease progression. We investigated the possible immunologic basis of this interaction by comparing older (у45 years) and younger (р30 years) HIV-infected adults with simultaneously enrolled, aged-matched, healthy volunteers. Cross-sectional comparisons suggested age-associated reductions in naive CD8 + cells and in the expression of CD28 + on CD8 + cells among both HIV-infected subjects and control subjects. Opposite patterns of CD4 + and CD8 + cell differences were apparent between these subject groups. HIV infection, but not age, was associated with impairments in delayed-type hypersensitivity responses, lymphoproliferation, and spontaneous apoptosis and with alterations in expression of chemokine receptors CCR5 and CXCR4. Reduced thymic volumes were associated with age and with HIV infection among younger, but not older, subjects. Because of their common association with age and HIV disease, naive CD8 + cell depletion, diminished CD28 expression on CD8 + cells, and reduced thymic volumes are possible correlates of the interaction of age with HIV disease.
retroviral therapies [1] [2] [3] [4] [5] [6] . Although the precise mechanisms that underlie this relationship are currently unknown, HIVmediated immune dysfunction and immunosenescence are each associated with a number of common immune perturbations, including impaired thymic function, with a systemic shift in the ratio of circulating naive to memory lymphocyte phenotypes [7] [8] [9] [10] [11] ; increased expression on circulating T cells of the activation marker HLA-DR [12] [13] [14] [15] [16] and of the receptor for Fas-mediated apoptosis, CD95 (APO-1/Fas) [17] [18] [19] ; diminished expression on circulating CD8 + T cells of the costimulatory molecule CD28 + [20] [21] [22] ; enhanced susceptibility of lymphocytes to spontaneous and activation-induced apoptosis [23] [24] [25] [26] ; impaired B cell, T cell, and NK cell signaling and effector function [7, [27] [28] [29] [30] ; impaired lymphoproliferative responses to mitogens and to antigens [31] [32] [33] ; and impaired delayed-type hypersensitivity (DTH) responses [33, 34] . Moreover, older age is also associated with blunted CD4 + and naive CD4 + T cell responses to antiretroviral therapy [35, 36] .
Because of these many common immune defects, we postulate that an immune basis may underlie the interaction of age with HIV disease progression. We sought to identify potential immune correlates of this interaction by comparing a broad array of immune indices in age-differentiated, HIV-infected subjects and healthy, age-matched control subjects. We reason that such correlates may include those perturbations that are common to both older age and HIV infection. The present article describes the results of a cross-sectional analysis of such a comparison.
SUBJECTS AND METHODS
Study design and study subjects. This is a multicenter, crosssectional analysis of HIV-1-infected subjects and healthy control subjects between 18 and 30 years or у45 years old. HIVinfected subjects had CD4 + cell counts !600 cells/mL and plasma HIV RNA levels 12000 copies/mL and were naive to antiretroviral therapy. Potential participants were excluded if they had experienced any medical illness for which systemic therapy was prescribed within the previous 30 days; if they had needed hospitalization within the previous 90 days; if they had received any immunomodulatory therapies within 6 months of enrollment; or if they had a history of malignancy. Women who were pregnant or breast-feeding also could not participate in this study. Additional laboratory criteria for participation included a hemoglobin concentration 19.1 g/dL for men and 18.9 g/dL for women; an absolute neutrophil count 1750 cells/mL; a platelet count у50,000 platelets/mL; serum alanine aminotransferase and aspartate aminotransferase levels !5 times the upper limit of normal; a serum creatinine level !2 times the upper limit of normal; and serum bilirubin and serum amylase levels !1.5 times the upper limit of normal.
Virologic and immunologic studies. Plasma HIV-1 RNA levels were measured using quantitative HIV-1 RNA polymerase chain reaction assays (Amplicor HIV-1 Monitor; Roche Molecular Systems) with a sensitivity of 50 copies/mL. Lymphocyte subsets were enumerated in freshly obtained whole blood with directly labeled murine monoclonal antibodies against CD3, CD4, CD8, CD16, CD19, CD28, CD38, CD56, CD95, CD45RA, CD45RO, and HLA-DR (PharMingen) and 3-color flow cytometry by use of the Adult AIDS Clinical Trials Group (AACTG) consensus immunology protocols [37] . Naive cells were defined as CD45RA + CD62L + ; memory cells, as CD45RO + CD45RA Ϫ ; NK cells, as CD3 Ϫ CD16 + CD56 + ; and B cells, as CD19 + . Absolute lymphocyte counts were derived from complete blood counts and leukocyte differential counts.
CXCR4 and CCR5 receptor densities were determined from measurements of immunofluorescence intensity, using a combination of monoclonal antibodies that bind to these receptors (purchased from PharMingen) and quantiBRITE PE beads (Biosciences Immunocytometry Systems). The number of antibodies bound per cell was calculated using the Quantiquest and CellQuest software with a FACSCalibur flow cytometer (Becton Dickinson) according to AACTG consensus immunology protocols [37] .
Peripheral blood mononuclear cells (PBMCs) were prepared by ficoll-hypaque density sedimentation, and these freshly prepared cells were used for lymphoproliferation and spontaneous apoptosis assays. Lymphoproliferation was assayed by measurement of [ 3 H]thymidine incorporation in response to Candida albicans antigen (20 mg/mL; Greer Laboratories), tetanus toxoid (2 limit-of-flocculation units [lfu]/mL; Aventis Pasteur), cytomegalovirus (1:20 dilution; BioWhittaker), Mycobacterium avium complex antigen (5 mg/mL; prepared and kindly donated by R. Wallis, University of Medicine and Dentistry of New Jersey, Newark), and hepatitis A virus antigen (0.25 mg/ mL; Chiron). Results are expressed as the stimulation index, defined as the ratio of the median counts per minute of quadruplicate cultures with antigen to the median counts per minute in culture medium alone without antigen, and were analyzed as a continuous outcome.
Spontaneous apoptosis was measured in freshly prepared cells that were cultured in median alone for 48 h, fixed in methanol, and stained with propidium iodide. Cells with hypodiploid DNA content were identified as apoptotic, as described in the AACTG consensus methods [37] . DTH responses to intradermal administration of antigens of C. albicans (Candin; Allermed Laboratories), mumps skin-test antigen (40 cfu/mL; Aventis Pasteur), tetanus toxoid fluid (4 lfu/0.5 mL; Aventis Pasteur), and purified protein derivative of M. tuberculosis (5 tuberculin units; Aventis Pasteur) were measured, using the ballpoint pen technique, after 48-72 h [38] . A positive reaction was defined as у5 mm of induration. Asian
Compared with the control group, the group of HIV-infected subjects included significantly more nonwhite participants and significantly fewer women ( ). "Older" subjects were у45 P ! .0001 years of age; "younger" subjects were !45 years of age.
Thymic volumes were estimated from noncontrast chest computed tomographic scans consisting of 5-mm sections from the sternal notch through the xiphoid process. Thymic scores were assigned on the basis of the consensus of 2 readers (B.H.G. and I.R.F.) who were blinded to the age and HIV serostatus of the subjects. Volumes were scored on a scale of 0-5, as follows: 0, no visible thymic tissue (i.e., thymic tissue entirely replaced by fat); 1, minimal, barely recognizable soft tissue; 2, minimal but more obvious soft tissue; 3, moderate thymic tissue; 4, moderate soft tissue, greater extent; and 5, thymic mass raising concern about thymoma [39].
Statistical analysis. The primary objective of this study was to compare naive CD4 + cell counts and percentages at baseline in 91 HIV-infected subjects who were enrolled in a prospective treatment study of antiretroviral therapy (AACTG Protocol 5015) with healthy volunteers who were simultaneously enrolled (AACTG Protocol 5113). Each subject group was evenly divided into 2 subgroups, older (у45 years) and younger (!45 years) participants, and groups were compared by intragroup comparisons (older vs. younger, among either HIV-infected or healthy subjects) and by intergroup comparisons (HIV infected vs. healthy, among either older or younger subjects) using Wilcoxon rank sum tests. Possible correlates of age-associated accelerated HIV disease progression included those indices that were similarly and significantly associated with age, as determined by intragroup comparisons among both HIV-infected and healthy subjects, and with HIV infection, as determined by at least 1 intergroup comparison among older and younger subjects. Statistical significance for the primary end point required a 2-tailed , reflecting a Bonferroni P ! .0125 adjustment for multiple testing, with an estimated sample size of 48 control subjects, to ensure a power of 80% to detect these differences. Statistical significance for all other end points required a 2-tailed ; because these were not adjusted for P ! .05 multiple testing, they are considered to be exploratory. With the exception of the secondary end points of DTH responses and thymic volumes, all values represent the means of the preentry and entry evaluations that were collected within 21 days (for HIV-infected subjects) or within 2 days (for healthy control subjects) of each other. Because of imbalances in race and sex between the HIV-infected subjects and the healthy control subjects, an additional analysis stratified for sex and race (white vs. nonwhite) was performed on the comparisons of T cell phenotypes, B cells, and NK cells.
RESULTS
Between October 2000 and August 2001, 91 HIV-infected subjects enrolled in a study of antiretroviral therapy at 26 participating AACTG sites. Forty-eight control subjects enrolled at 9 of these sites between April and September 2001. Compared with the group of HIV-infected subjects, the healthy control group included significantly more women and significantly fewer African-Americans and Latinos ( ; table 1 ). Nom-P ! .0001 inally significant intra-and intergroup differences are summarized in table 2. The median log 10 virus load was higher among the older HIV-infected subjects (4.81 vs. 4.45 log 10 copies/mL), but this difference was not statistically significant ( ) . P p .085 T cell phenotypes. HIV-associated differences, as determined by intergroup comparisons, were similar among both older and younger subjects and included fewer CD4 + and more CD8 + cells, fewer naive CD4 + and CD8 + cells, and proportionately more memory CD4 + and CD8 + cells in HIV-infected subjects than in healthy control subjects. HIV infection also was associated with greater expression of HLA-DR/CD38 and CD95 and lower expression of CD28 on both CD4 + and CD8 + cells (tables 2 and 3). 
Percentage of CD4 + HLA-DR + CD38 + cells
Thymic volume f f f NOTE. For the primary end point, naive CD4 + cell counts, indicated a significant difference; for all other com-P ! .0125 parisons, was considered to indicate a statistically significant difference. P was !.001 for all comparisons, unless P ! .05 otherwise indicated. "Older" subjects were у45 years of age; "younger" subjects were !45 years of age. DTH, delayed-type hypersensitivity; LPA, lymphoproliferation assay; MAC, Mycobacterium avium complex; F, significantly greater in the older group, by intragroup comparison, or in the HIV-infected group, by intergroup comparison; f, significant smaller in the older group or in the HIV-infected group.
a Difference was not significant in the analysis stratified for race and sex. b . P ! .05 Age-associated differences depended in part on the HIV serostatus of the subjects. Among both the HIV-infected subjects and the control subjects, older age was associated with fewer naive (CD45RA + CD62L + ) CD8 + cells and lower CD28 expression on CD8 + cells (lower CD8 + CD28 + percentages for HIVinfected subjects and fewer CD8 + CD28 + cells for control subjects; tables 2 and 3). Older age was associated with opposite differences in CD4 + and CD8 + cells in these subject groups, however: lower CD4 + cell counts and percentages and high-er CD8 + cell percentages were seen in HIV-infected subjects, and lower CD8 + cell counts and percentages and higher CD4 + cell percentages were seen in control subjects. With the exception of HLA-DR/CD38 expression, many of the significant T cell perturbations that were associated with HIV infection in younger HIV-infected subjects were present in their older counterparts. Additional age-associated differences among healthy control subjects included fewer CD8 + HLA-DR + CD38 + cells in older participants. The results of a stratified analysis that ac- Figure 1 . Delayed-type hypersensitivity responses to selected skintest antigens. Human immunodeficiency virus (HIV) infection, but not older age, was associated with significant differences in response to mumps (dark gray columns), tetanus (light gray columns) ( , among both P ! .001 older and younger subjects, for both mumps and tetanus), and Candida (black columns;
, among older subjects, and , among P p .032 P p .005 younger subjects) skin-test antigens.
counted for the imbalance in race and sex between the 2 subject groups were not substantially different from those of the original analysis (table 2) .
NK cells, CD3 + CD16 + CD56 + cells, and B cells.
No significant age-related differences in NK (CD3 Ϫ CD16 + CD56 + ) cells or in CD3 + CD16 + CD56 + cells were apparent by intragroup comparisons among either the HIV-infected subjects or the control subjects. HIV infection was associated with significantly fewer NK cells among both older and younger subjects (tables 2 and 3).
Age-associated reductions in the percentage of B cells were apparent in older HIV-infected subjects but not in healthy control subjects. HIV infection also was significantly associated with lower B cell counts and percentages among both older and younger subjects (tables 2 and 3).
Chemokine receptor densities. There were no apparent age-associated differences in CCR5 or CXCR4 densities on CD4 + cells or CD14 + monocytes among either the HIV-infected or the control subjects. HIV infection was associated with significantly higher CCR5 receptor densities on CD4 + cells and significantly lower CXCR4 receptor densities on CD14 + monocytes among both older and younger subjects (tables 2 and 3).
DTH, lymphoproliferation, and spontaneous apoptosis assays.
There were no significant age-associated differences in DTH responses among either the HIV-infected subjects or the control subjects (table 2 and figure 1). HIV infection was associated with significantly lower skin-test response rates to tetanus, mumps, and Candida antigens among both older and younger subjects.
Lymphoproliferative responses to tetanus were significantly lower among older HIV-infected subjects than among their younger counterparts, but significant age-related differences were not apparent in response to other antigens or mitogens (table 2 and figure 2). HIV infection was associated with significantly lower lymphoproliferative responses to pokeweed mitogen, by intergroup comparisons among older HIV-infected subjects, and to tetanus, M. avium complex, and Candida antigens among both older and younger subjects. Although HIV infection was associated with significantly higher percentages of lymphocytes that underwent spontaneous apoptosis among both older and younger subjects, there were no apparent ageassociated differences in spontaneous apoptosis in either subject group (table 2) .
Thymic volumes. The older subjects in both groups had thymic volumes that were significantly lower, as estimated by thymic scores derived from computed tomography, than those of their younger counterparts. HIV infection was associated with lower thymic volumes among the younger subjects, whereas the older subjects in both groups had similar thymic volumes (table 2 and figure 3) .
DISCUSSION
To identify possible correlates that may underlie the interaction of age with HIV disease, in this study we sought to identify immune perturbations that were common to both conditions. Because age has an impact on adult HIV disease progression early in adulthood, the range of ages that we examined was narrow, compared with the broader ranges that are typical of most immunogeriatric studies. To avoid possible confounding effects of comorbidities or medications, the entry criteria for the control subjects were largely consistent with the Senieur protocol, standardized laboratory and clinical entry criteria that are recommended for immunogeriatric studies [40] . Despite the imbalance in race and sex between the HIV-infected subjects and the healthy control subjects, the intergroup differences in T cell phenotypes, B cells, and NK cells that were observed in this study are consistent with previously well-characterized, HIV-associated changes in these cells, which were not substantially altered in the additional stratified analysis that was performed to account for this imbalance.
HIV-associated immune perturbations were largely similar in older and younger subjects. Age-associated perturbations depended in part on the HIV serostatus of the subjects examined, however. Among both the HIV-infected subjects and the healthy control subjects, older age was associated with fewer naive CD8 + cells and diminished CD28 expression on CD8 + Figure 2 . Lymphoproliferative responses to selected antigens. Box plots indicate interquartile ranges; lines within the boxes indicate median values; and whiskers indicate ranges. Human immunodeficiency virus (HIV) infection was associated with significant differences in response to Mycobacterium avium complex (MAC; dark gray columns;
, among P ! .001 older subjects, and , among younger subjects), tetanus (light P p .005 gray columns;
, among both older and younger subjects), and P ! .001 Candida antigens (black columns;
, among older subjects, and P ! .001 , among younger subjects). Age was only associated with sig-P p .003 nificant differences in response to tetanus antigen among HIV-infected subjects ( ). P p .033 ). Among younger P ! .001 subjects, human immunodeficiency virus (HIV)-infected subjects (black columns) had significantly lower thymic scores than did control subjects (white columns) (
). See Methods for a description of thymic P p .010 scores.
cells. Age was associated with opposite patterns of differences in CD4 + and CD8 + cells in the 2 subject groups. Among HIVinfected subjects, many of the age-related differences in other T cell phenotypes and in B cells were similar to those that were associated with HIV disease itself, which suggests that older age may accentuate these HIV-related differences. HIV infection, but not age, was associated with differences in the expression of chemokine receptor densities, DTH responses, and spontaneous apoptosis of lymphocytes. HIV infection also was associated with diminished lymphoproliferative responses to mitogens and antigens, whereas significant age-associated differences in lymphoproliferation only were apparent in HIVinfected subjects and in response to tetanus antigen. Finally, older age was associated with lower thymic volumes, but HIVassociated differences in thymic volumes were evident among younger, but not older, subjects.
Reductions in naive CD4 + and CD8 + T cell counts are characteristic of both immunosenescence and HIV disease. In both conditions, and consistent with the results of the present study, this relationship is stronger for naive CD8 + cells than for naive CD4 + cells [9] [10] [11] .
Diminished expression of CD28 on CD8 + cells is characteristic of aging [20] . The importance of this T cell costimulatory molecule in the immunopathogenesis of AIDS is suggested by the observation that diminished frequency of CD28 expression on CD4 + and CD8 + cells correlates with HIV-1 disease progression and predicts suboptimal in vivo responses to immunization in HIV disease [21, 22, 41, 42] . Appropriate T cell activation, proliferation, and differentiation results from the simultaneous engagement of the T cell receptor and CD28, which is expressed on naive and primed T cells [43] ; T cell receptor stimulation in the absence of CD28 ligation often results in anergic responses. CD28 activation also results in upregulation of antiapoptotic molecules and enhanced expression of T helper cytokines. Despite the effect of CD28 on apoptosis, we did not observe an association between age and spontaneous apoptosis.
Age-associated reductions in CD8 + cells have been consistently demonstrated among healthy subjects, but changes in CD4 + cells have been variously described as increasing, decreasing, or unchanged with older age [29] . CD4 + cell depletion is the hallmark of HIV infection, and yet CD8 + cell depletion is more consistently associated with immunosenescence [7, 8] .
With the exception of HLA-DR/CD38 expression on CD4 + and CD8 + cells, older age appeared to accentuate many HIVassociated changes in T cell phenotypes and B cells in HIV-infected subjects. Because of the cross-sectional design of this study, however, we cannot exclude the possibility that these intragroup differences may simply reflect an imbalance in the severity of HIV disease, with more advanced disease in the older subjects. The lack of age-associated differences in CD8 + HLA-DR + CD38 + cells is noteworthy, given the independent association of HLA-DR/CD38 expression with HIV disease progression and the positive correlation of this marker of T cell activation with T cell depletion [14] [15] [16] 44] . Together with the age-associated reductions in CD8 + HLA-DR + CD38 + cells that were apparent among older healthy control subjects, these differences in HLA-DR/CD38 expression represent an additional possible distinction between immunosenescence and HIV-mediated immune dysfunction.
We did not observe an association between age and chemokine receptor densities on CD4 + cells or CD14 + monocytes. HIV infection has been associated with up-regulation of CCR5 receptors on CD4 + cells and down-regulation of CXCR4 on CD14 + monocytes [45] , which is consistent with the results of the present study. The present study is also consistent with the previous studies [25, 33] in its finding of a significant relationship between HIV disease and impaired lymphoproliferative responses to antigens, diminished DTH responses to skin-test antigens, and increased spontaneous apoptosis of lymphocytes. Although older subjects demonstrated weaker lymphoproliferative responses to tetanus, cytomegalovirus, and Candida antigens, only the difference in the response to tetanus antigen was statistically significant, and only among older HIV-infected subjects. Similarly, lower skin test responses to tetanus and Candida antigens were apparent among older subjects of both groups, but these differences were not statistically significant.
As expected, and in keeping with the findings of a previous study [39] , older age was associated with reduced thymic volumes in both subject groups. HIV infection was associated with reduced thymic volumes among younger, but not older, subjects. This observation contrasts with the findings of the abovecited study, which demonstrated the persistence of abundant thymic tissue (grade 3 or greater) in 5 of 10 older (139 years) HIV-infected subjects but of none of 10 HIV-seronegative, agematched control subjects. Although the reliability of the technique that we used to measure thymic volumes has not been formally assessed, its validity is supported by correlations of thymic volume measured by this technique with age, naive T cell phenotype, and T cell reconstitution in response to antiretroviral therapy [39, 46, 47] .
A better understanding of the interaction of age with HIV disease might provide insight into key mechanisms that underlie the immunopathogenesis of both processes. Potential immune correlates of this interaction may include those that are common to both. This study directly and uniquely compared a comprehensive array of candidate immune indices over an age range that is relevant to adult HIV disease. We identified naive CD8 + cell depletion, reduced CD28 expression on CD8 + cells, and reduced thymic volumes as fulfilling this criterion. We also demonstrated several distinctions between aging and HIV with respect to other demonstrated and putative correlates of HIV disease progression, including CD4 + cells, the expression of HLA-DR and CD38 on CD8 + cells, and CCR5 receptor expression on CD4 + cells.
These findings should be considered exploratory, given the cross-sectional design of this study and because each variable was subjected to multiple comparisons. Further clarification of these and other possible immune correlates of the interaction of age with HIV disease progression might be afforded by additional correlations with differences in immune reconstitution in response to antiretroviral therapy or with functional immune responses. Toward that end, the immune and viral responses to a uniform antiretroviral regimen will be compared among the HIV-infected participants of the present study.
